NCT07431593 (SIMO-PRO) is a clinical trial of Nutritional counselling in Overweight and Obesity, sponsored by University of Rijeka.

Who is sponsoring NCT07431593?

NCT07431593 is sponsored by University of Rijeka.

What drugs are being tested in NCT07431593?

Interventions in NCT07431593: Nutritional counselling.

What condition does NCT07431593 study?

NCT07431593 studies Overweight and Obesity, Inflammation, Metabolic Syndrome.

Is NCT07431593 still recruiting?

NCT07431593 is currently not yet recruiting. Last updated 24 February 2026.

Last reviewed 2026-02-24 · How we verify

NCT07431593: SIMO-PRO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications

Not yet recruiting Last updated 24 February 2026

What this trial tests

trial testing Nutritional counselling in Overweight and Obesity in 200 participants. Not yet recruiting.

Timeline

2 February 2026

Primary endpoint
28 February 2027

31 December 2027

Quick facts

Lead sponsor	University of Rijeka
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	2 February 2026
Primary completion	28 February 2027
Estimated completion	31 December 2027

Drugs / interventions tested

Nutritional counselling

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →
Inflammation — all drugs for Inflammation →
Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

University of Rijeka

Who can join

18 and older, any sex, with Overweight and Obesity or Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study aims to evaluate the diagnostic and prognostic value of the systemic immune-inflammatory index (SII) and the systemic inflammation response index (SIRI) in individuals with overweight or obesity. The study will assess their association with obesity status, metabolic complications, lifestyle patterns, dietary indices, and established inflammatory biomarkers. Participants will undergo anthropometric assessment, laboratory testing, dietary evaluation, and follow-up for response to different obesity treatment modalities over 3 years. The study intends to determine whether SII and SIRI can serve as clinically useful predictors of metabolic risk and treatment outcomes of obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nutritional counselling

Trials testing the same drug.

NCT06830967 — Virtual Prehabilitation for Patients Undergoing Abdominal Aortic Aneurysm Repair · NA · not yet recruiting
NCT06797739 — Effect of Nutritional Counseling and Mediterranean Diet on Patients With Diverticular Disease · NA · active not recruiting
NCT04746664 — Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life · NA · completed
NCT04217564 — Nutritional Counselling for Patients at Kasr AlAiny Multiple Sclerosis Clinic: an Intervention Study · NA · completed
NCT03582826 — Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions · NA · completed

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other University of Rijeka trials

Trials by the same sponsor.

NCT07481422 — Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndro · Phase 1, PHASE2 · recruiting
NCT06925399 — Changes in Natural Immunity in Pregnant Women With Autoimmune Thyroid Disease · not yet recruiting
NCT05719519 — Change in Gingival Volume and Quality of Life Due to Initial Periodontal Therapy in Smokers · NA · unknown
NCT07170215 — Effect of Anti-gravity Treadmill Training After Total Hip Arthroplasty · NA · completed
NCT06191497 — The Effect of Smoking and Chlorhexidine on Periodontal Tissues After Non- Surgical Periodontal Therapy in Patients With · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07431593 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rijeka
Last refreshed: 24 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07431593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing